Sumbul Khalid
Impact in
- Pharmacology top 10%
- Berberine and alkaloids research
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Metabolism, Diabetes, and Cancer 4
-
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Ammad Ahmad Farooqı (11 shared papers)Baojun Xu (4 shared papers)Aamir Ahmad (1 shared paper)Kumar Ganesan (1 shared paper)Muthukumaran Jayachandran (1 shared paper)Rükset Attar (5 shared papers)Muhammad Zahid Qureshi (5 shared papers)Uteuliyev Yerzhan Sabitaliyevich (2 shared papers)
In The Last Decade
Sumbul Khalid
25 papers receiving 417 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 59
- Cancer Research 77
- Geriatrics and Gerontology 20
- Molecular Medicine 20
- Complementary and alternative medicine 31
Countries citing papers authored by Sumbul Khalid
This map shows the geographic impact of Sumbul Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumbul Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumbul Khalid more than expected).
Fields of papers citing papers by Sumbul Khalid
This network shows the impact of papers produced by Sumbul Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumbul Khalid. The network helps show where Sumbul Khalid may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumbul Khalid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2018 | 53 | |
| 3 | 2019 | 49 | |
| 4 | 2018 | 45 | |
| 5 | 2011 | 39 | |
| 6 | 2018 | 20 | |
| 7 | 2016 | 19 | |
| 8 | 2018 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2018 | 17 | |
| 11 | 2017 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 8 | |
| 14 | 2016 | 7 | |
| 15 | 2017 | 6 | |
| 16 | 2015 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2017 | 4 | |
| 20 | Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients. | 2019 | 4 |
About Sumbul Khalid
Sumbul Khalid is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 25 papers that have together received 424 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (4 papers), Cancer Mechanisms and Therapy (4 papers), MicroRNA in disease regulation (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Poisoning and overdose treatments (2 papers), Diabetes Treatment and Management (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (59 citations), Cancer Research (77 citations), Geriatrics and Gerontology (20 citations), Molecular Medicine (20 citations) and Complementary and alternative medicine (31 citations). Sumbul Khalid has collaborated with scholars based in Pakistan, Türkiye and China. Frequent co-authors include Ammad Ahmad Farooqı, Baojun Xu, Aamir Ahmad, Kumar Ganesan, Muthukumaran Jayachandran, Rükset Attar, Muhammad Zahid Qureshi, Uteuliyev Yerzhan Sabitaliyevich, Aliye Aras and Samuel Singer. Their work appears in journals such as Cellular and Molecular Biology, Food and Chemical Toxicology, Journal of Cellular Biochemistry, Annals of Human Genetics and Critical Reviews in Eukaryotic Gene Expression.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.